Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
The full text of each resolution is set out in the Notice of Annual General Meeting, included in the 2017 Annual Report, which is available here.